The Evolution of Data 3.0

whitePaper | August 9, 2022

Data virtualization helps organizations access data across disparate sources and deliver a unified view of the data faster, cheaper, and using fewer resources than traditional data integration approaches. In this TEI, data virtualization delivered 83% reduction in time-torevenue and 65% decrease in delivery times over extract, transform, and load (ETL) processes.

whitePaper | October 5, 2022

As we assess the global business environment in the latter half of 2022, perhaps the best single word that describes the state of play is uncertainty. Planning for uncertainties is a significant part of what we, as business executives and individuals, do on a daily basis. In times of uncertainty, brands realize they must work even harder to retain customers and deepen relationships by delivering value and empathy at scale. As we analyze our uncertainties, we can take comfort and guidance from management guru Peter Drucker, who wrote that “strategy aims to exploit the new and different opportunities of tomorrow” (Managing in Turbulent Times, 1980).

whitePaper | June 24, 2022

The reactive approach to discovering, analyzing, and correcting data quality issues in business applications has been marginally effective throughout the era of data consolidation for analytics (data warehousing, etc.) and the subsequent onset of “big data.”

whitePaper | May 6, 2022

Every organization today recognizes the strategic value of generating actionable insights from their enterprise data.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | September 22, 2022

This report introduces the Climate Data Steering Committee (the Committee or CDSC)’s proposed recommendations for the development of an open data utility for climate transition-related data: the Net-Zero Data Public Utility (the Utility or NZDPU). The Utility is designed to be built as part of ongoing enhancements to the United Nations Framework Convention on Climate Change (UNFCCC)'s Global Climate Action Portal and will therefore also support increased integration of private sector commitments and actions within the UNFCCC stocktaking and recognition processes.